New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.

The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.

Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.

Go Back

Share this story

Comments


Related articles


Matt Eagles_ParkinsonsEU

PD in Practice

Are impulse control disorders the last Parkinson’s ‘taboo’?

New PD guidelines updates focus on impulse control disorders

READ MORE
Parkinson's Sidekicks

Interviews

Parkinson’s Sidekicks: bridging the intergenerational gap

A US art initiative tackling social isolation in Parkinson’s

READ MORE

Perspectives

Billy Connolly “doing really well, funny as ever,” says wife

Pamela Stephenson gives an update on her husband’s condition

READ MORE